Tag: ovarian

Human papillomavirus (HPV) vaccine is used to prevent sexually transmitted HPV infections and cervical cancers. People who are not vaccinated and contract HPV may experience future fertility problems associated with the infection. The vaccine currently approved by the FDA has been extensively tested and demonstrated to be both safe and effective with limited side effects.

IUDs can lower a woman’s risk of developing ovarian cancer by more than 30%, study finds Women who used intrauterine devices (IUDs) for birth control could lower their risk of ovarian cancer by between 15% and 32% The risk was mitigated whether women used hormonal or non-hormonal IUDs  Researchers believe it’s because IUDs combat estrogen, the hormone

A team of researchers from Clemson University and Prisma Health-Upstate are working to create a screening process to catch ovarian cancer in the early or pre-cancerous stages. Their goal is to make this screening as simple and easy for women as getting a pap smear. The idea is to identify the pre-cancerous changes through the

In the United States, ovarian cancer has the highest mortality rate of all gynecologic cancers, according to the Centers for Disease Control and Prevention (CDC). In 2014, for instance, over 21,000 new cases of ovarian cancer occurred, at least 14,000 of which resulted in death. Previous research has suggested that combined oral contraceptives — that

New types of combined oral contraceptives (containing both lower doses of oestrogens and newer progestogens) are associated with a reduced risk of ovarian cancer, in young women, finds a large study published by The BMJ today. The results show that this positive effect strengthened with longer periods of use and persisted for several years after

A new study, led by the University of Chicago in Illinois, has unraveled the role of glycogen in fueling ovarian cancer spread. It is the first to reveal how tumor cells interact with support cells called cancer-associated fibroblasts to make this happen. “No systematic study,” says senior study author Ernst Lengyel, who is a professor

Scientists at the Ovarian Cancer Action Research Centre at Imperial College London have discovered a mechanism that deactivates ovarian cancer cells. The findings, published in EMBO Reports, could lead to better treatments for women with ovarian cancer. The research has found a new mechanism for a protein named OPCML. This protein is known as a

Premenopausal women with hormone receptor-positive, HER2-negative breast cancer and a high risk of recurrence who are treated with an aromatase inhibitor plus ovarian function suppression may gain 10 to 15 percent improvement in freedom from distant recurrence at eight years, according to a new clinical trial analysis reported at the annual meeting of the American